Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was SEK 22.79 million compared to SEK 27.75 million a year ago. Revenue was SEK 24.08 million compared to SEK 28.98 million a year ago. Net loss was SEK 13.75 million compared to SEK 6.64 million a year ago. Basic loss per share from continuing operations was SEK 0.19 compared to SEK 0.09 a year ago.